Novartis AG (0QLR.IL)
IOB - IOB Delayed price. Currency in CHF
Add to watchlist
As of 03:20PM BST. Market open.
| Previous close | 79.81 |
| Open | 81.00 |
| Bid | 78.90 x N/A |
| Ask | 82.94 x N/A |
| Day's range | 80.80 - 81.92 |
| 52-week range | 72.84 - 89.28 |
| Volume | |
| Avg. volume | 1,285,663 |
| Market cap | 181.256B |
| Beta (5Y monthly) | 0.48 |
| PE ratio (TTM) | 7.81 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.10 (3.90%) |
| Ex-dividend date | 08 Mar 2022 |
| 1y target est | N/A |
- Zacks
Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates
The FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and Novartis's (NVS) cancer combination drugs, Tafinlar (dabrafenib) + Mekinist (trametinib).
- Zacks
Novartis' (NVS) Oncology Drugs Get Approval for Label Expansion
Novartis (NVS) obtains regulatory approval for label expansion of Tafinlar + Mekinist and Tabrecta.
- Zacks
Precision BioSciences' (DTIL) Stock Up This Week: Here's Why
Shares of Precision BioSciences (DTIL) are up as the company inks a gene-editing deal with Novartis to develop a potentially curative treatment for disorders like sickle cell disease.
© 2022 Yahoo. All rights reserved.
